Pfizer Inc

PFENYSE · USD
27.66USD0.00 (+0.08%)
877

Pfizer Inc (PFE) Implied Volatility Current

PFE implied volatility is 21%. IV Rank is 10%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking PFE implied volatility helps you identify when options premiums on Pfizer Inc are historically cheap or expensive, and where the best trades are hiding. Pfizer Inc implied volatility reflects the market's expectation of future price movement: when PFE IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Pfizer Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PFE, tracking metrics like PFE IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PFE signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands.

In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PFE implied volatility sits today versus where it has been. Our scanner ranks Pfizer Inc implied volatility against its historical range, surfaces extremes in PFE IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Pfizer Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
9.92%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)21.00%

IV Rank9.92%

Historical Volatility (30d)21.19%

IV - HV-0.19%

As of September 18, 2026

Trade options with IV on your side

Track PFE IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial